ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer
Most Recently Serving as President for Oticon, a Division of Demant, Rosenblum Brings 30+ Years of Experience in Medical Technology and Consumer Healthcare to ZEISS... Read more.
DBI Investors Have Opportunity to Join Designer Brands Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$DBI—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
Game-Changing “Solo Scan” by Arvie Transforms Campsite Booking — Free Nationwide Until July 4th —
Arvie.com offers FREE AutoBook scans to ALL campers from now through the long 4th of July weekend. “Put Arvie to the test to find & book an unexpected spot... Read more.
HIMS & HERS HEALTH INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc. – HIMS
NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick... Read more.
HIMS BREAKING NEWS: Hims & Hers Health, Inc. is being Investigated for Securities Fraud; Investors with Losses are Notified to Contact BFA Law
NEW YORK–(BUSINESS WIRE)–$HIMS #Attorney–Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims &... Read more.
Crescent Energy Announces Pricing of Upsized $600 Million Private Placement of 8.375% Senior Notes Due 2034
HOUSTON–(BUSINESS WIRE)–Crescent Energy Company (NYSE: CRGY) (“we” or “our”) announced today that its indirect subsidiary Crescent Energy Finance... Read more.
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
WESTMINSTER, Colo.–(BUSINESS WIRE)–TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a company working to improve outcomes for patients with solid tumors... Read more.
KBRA Assigns Preliminary Ratings to Point Broadband Funding, LLC, Series 2025-1 Senior Secured Notes
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns preliminary ratings to the Series 2025-1 Class A-1-V Notes, Class A-1-L Notes, Class... Read more.
KBRA Assigns Preliminary Ratings to GLS Auto Select Receivables Issuer Trust 2025-3
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns preliminary ratings to four classes of notes (five tranches) issued by GLS Auto Select... Read more.
DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Based on TROPION-Lung05 phase 2 trial results and supported by data from the TROPION-Lung01 phase 3 trial Second U.S. approval for Daiichi Sankyo and AstraZeneca’s... Read more.